Bank of America’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bank of America’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,300	Closed	-$90K	–	8111
2014 Q4	$90K	Sell	5,300 -59,900	-92%	-$843K	﹤0.01%	5968
2014 Q3	$777K	Buy	65,200 +57,900	+793%	+$395K	﹤0.01%	4199
2014 Q2	$41K	Sell	7,300 -14,700	-67%	-$67.7K	﹤0.01%	6798
2014 Q1	$81K	Sell	22,000 -13,000	-37%	-$49.5K	﹤0.01%	6135
2013 Q4	$118K	Buy	35,000 +30,800	+733%	+$127K	﹤0.01%	6005
2013 Q3	$18K	Sell	4,200 -4,500	-52%	-$21.3K	﹤0.01%	6942
2013 Q2	$40K	Buy	+8,700	New	+$29.9K	﹤0.01%	6688

Bank of America's AVNR Position: Q1 2015 in Review

Bank of America sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 19,451 shares — an estimated $330K sold.

Bank of America first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $1.24M in Q3 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Bank of America reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Bank of America sold 19,451 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $330K.
Bank of America first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Bank of America's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.24M in Q3 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Bank of America's 13F filing for Q1 2015, filed 15 May 2015.